Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 531 in Thrombocytopenic Subjects With ITP
NCT00111475Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 2002
- Primary completion
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of romiplostim in immune thrombocytopenic purpura (ITP), sponsored by Amgen. Started Jul 2002; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00111475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111475.